Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JOEL MESHULAM

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1871513697
CMS profile
39011
Location
BALTIMORE, MD

General Payments · PY2018–2024

$2,243.90

  • Reported across 125 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$713.83

39 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $713.83 39

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $34.02 2
PY2020 $146.88 9
PY2021 $370.15 21
PY2022 $271.72 15
PY2023 $707.30 39
PY2024 $713.83 39

Payment records · PY2024 (39)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $17.23 03/28/2024 Food and Beverage Undisputed 01/23/2026 1125313594 CMS
Abbott Laboratories $24.91 06/03/2024 Food and Beverage Undisputed 01/23/2026 1125313596 CMS
ABBVIE INC. $1.85 01/09/2024 Food and Beverage Undisputed 01/23/2026 1105026438 CMS
ABBVIE INC. $12.81 01/09/2024 Food and Beverage Undisputed 01/23/2026 1105026440 CMS
ABBVIE INC. $27.23 03/27/2024 Food and Beverage Undisputed 01/23/2026 1105026442 CMS
ABBVIE INC. $20.24 04/30/2024 Food and Beverage Undisputed 01/23/2026 1105026444 CMS
ABBVIE INC. $20.63 08/13/2024 Food and Beverage Undisputed 01/23/2026 1105026446 CMS
ABBVIE INC. $6.25 08/28/2024 Food and Beverage Undisputed 01/23/2026 1105026448 CMS
ABBVIE INC. $8.85 08/28/2024 Food and Beverage Undisputed 01/23/2026 1105026450 CMS
ABBVIE INC. $27.04 09/06/2024 Food and Beverage Undisputed 01/23/2026 1105026452 CMS
ABBVIE INC. $10.80 10/02/2024 Food and Beverage Undisputed 01/23/2026 1105026454 CMS
ABBVIE INC. $15.02 10/02/2024 Food and Beverage Undisputed 01/23/2026 1105026456 CMS
Amgen Inc. $18.53 03/19/2024 Food and Beverage Undisputed 01/23/2026 1117327425 CMS
Amgen Inc. $16.35 08/27/2024 Food and Beverage Undisputed 01/23/2026 1117327427 CMS
AstraZeneca Pharmaceuticals LP $17.74 01/18/2024 Food and Beverage Undisputed 01/23/2026 1104649641 CMS
AstraZeneca Pharmaceuticals LP $14.08 02/14/2024 Food and Beverage Undisputed 01/23/2026 1104683811 CMS
AstraZeneca Pharmaceuticals LP $17.89 05/08/2024 Food and Beverage Undisputed 01/23/2026 1104624700 CMS
AstraZeneca Pharmaceuticals LP $17.22 07/30/2024 Food and Beverage Undisputed 01/23/2026 1104341792 CMS
Bayer Healthcare Pharmaceuticals Inc. $31.16 03/15/2024 Food and Beverage Undisputed 01/23/2026 1086167384 CMS
GlaxoSmithKline, LLC. $25.84 02/12/2024 Food and Beverage Undisputed 01/23/2026 1116511191 CMS
Lilly USA, LLC $18.20 01/03/2024 Food and Beverage Undisputed 01/23/2026 1135052600 CMS
Lilly USA, LLC $20.30 04/03/2024 Food and Beverage Undisputed 01/23/2026 1135068507 CMS
Lilly USA, LLC $18.92 07/16/2024 Food and Beverage Undisputed 01/23/2026 1135052062 CMS
Lilly USA, LLC $18.83 08/15/2024 Food and Beverage Undisputed 01/23/2026 1135065769 CMS
Lilly USA, LLC $17.76 10/29/2024 Food and Beverage Undisputed 01/23/2026 1135027068 CMS
Merck Sharp & Dohme LLC $17.61 10/16/2024 Food and Beverage Undisputed 01/23/2026 1141953413 CMS
Novartis Pharmaceuticals Corporation $22.20 02/21/2024 Food and Beverage Undisputed 01/23/2026 1087080168 CMS
Novartis Pharmaceuticals Corporation $26.61 07/03/2024 Food and Beverage Undisputed 01/23/2026 1087080184 CMS
Novartis Pharmaceuticals Corporation $22.61 09/19/2024 Food and Beverage Undisputed 01/23/2026 1087080200 CMS
Novartis Pharmaceuticals Corporation $19.12 12/12/2024 Food and Beverage Undisputed 01/23/2026 1087080216 CMS
Novo Nordisk Inc $21.73 02/06/2024 Food and Beverage Undisputed 01/23/2026 1096949675 CMS
Novo Nordisk Inc $13.54 05/16/2024 Food and Beverage Undisputed 01/23/2026 1096593576 CMS
Novo Nordisk Inc $21.42 07/10/2024 Food and Beverage Undisputed 01/23/2026 1097113285 CMS
Novo Nordisk Inc $13.98 08/14/2024 Food and Beverage Undisputed 01/23/2026 1097672505 CMS
Novo Nordisk Inc $16.01 10/17/2024 Food and Beverage Undisputed 01/23/2026 1097340453 CMS
PFIZER INC. $16.83 02/01/2024 Food and Beverage Undisputed 01/23/2026 1131049520 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.93 09/18/2024 Food and Beverage Undisputed 01/23/2026 1153408956 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.13 10/14/2024 Food and Beverage Undisputed 01/23/2026 1153686086 CMS
SANOFI PASTEUR INC. $21.43 01/31/2024 Food and Beverage Undisputed 01/23/2026 1128751371 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.